MacLean Michael F

Chief Financial Officer at Avidity Biosciences, Inc.; SVP, Chief Accounting Officer at BIIB

Sold, on record
$16.4M
Dollars the filings state
Form 4 sales
20
Latest Jan 21, 2026
Form 144 notices
5
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Avidity Biosciences, Inc.Unusual
    Nov 6, 2024 2024

    Sold 106,319 shares at $45.56 ($4.8M)

    MacLean Michael F, Chief Financial Officer

    10b5-1 planSold 53.1% of holdings ($9.1M position)94,093 shares left4.1x usual sizeFollows a Form 144Filing

  2. 2 Form 4 sale Avidity Biosciences, Inc.Routine
    Dec 18, 2024 +42 days

    Sold 11,151 shares at $32.66 ($364k)

    MacLean Michael F, Chief Financial Officer

    10b5-1 planSold 11.9% of holdings ($3.1M position)82,942 shares left0.3x usual sizeFiling

  3. 3 Form 4 sale Avidity Biosciences, Inc.Routine
    Jan 21, 2025 +34 days

    Sold 3,287 shares at $28.59 ($94k)

    MacLean Michael F, Chief Financial Officer

    10b5-1 planSold 3% of holdings ($3.1M position)104,655 shares left0.1x usual sizeFiling

  4. 4 Form 4 sale Avidity Biosciences, Inc.Routine
    Mar 20, 2025 +58 days

    Sold 7,935 shares at $31.06 ($246k)

    MacLean Michael F, Chief Financial Officer

    10b5-1 planSold 7.6% of holdings ($3.3M position)96,720 shares left0.7x usual sizeFiling

  5. 5 Form 144 notice Avidity Biosciences, Inc.Notice
    Aug 6, 2025 +139 days

    Filed to sell 30,914 shares ($1.2M)

    MacLean Michael F, Officer

    10b5-1 plan2.7x usual sizeFiling

  6. 6 Form 4 sale Avidity Biosciences, Inc.Routine
    Aug 6, 2025 same day

    Sold 30,914 shares at $42.73 ($1.3M)

    MacLean Michael F, Chief Financial Officer

    10b5-1 planSold 32% of holdings ($4.1M position)65,806 shares left2.7x usual sizeFollows a Form 144Filing

  7. 7 Form 4 sale Avidity Biosciences, Inc.Routine
    Jan 7, 2026 +154 days

    Sold 1,974 shares at $72.23 ($143k)

    MacLean Michael F, Chief Financial Officer

    10b5-1 planSold 3% of holdings ($4.8M position)63,832 shares left0.2x usual sizeFiling

  8. 8 Form 4 sale Avidity Biosciences, Inc.Routine
    Jan 21, 2026 +14 days

    Sold 4,542 shares at $72.45 ($329k)

    MacLean Michael F, Chief Financial Officer

    10b5-1 planSold 7.1% of holdings ($4.6M position)59,290 shares left0.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (25)

Form 144 notices and Form 4 sales by MacLean Michael F
Source
Jan 21, 2026Jan 23, 2026Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale4,542$329k7.1%RoutineSEC
Jan 7, 2026Jan 9, 2026Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale1,974$143k3.0%RoutineSEC
Aug 6, 2025Aug 15, 2025Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale30,914$1.3M32.0%RoutineSEC
Aug 6, 2025Aug 6, 2025Avidity Biosciences, Inc.OfficerForm 144 notice30,914$1.2MNoticeSEC
Mar 20, 2025Mar 21, 2025Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale7,935$246k7.6%RoutineSEC
Jan 21, 2025Jan 23, 2025Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale3,287$94k3.0%RoutineSEC
Dec 18, 2024Dec 19, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale11,151$364k11.9%RoutineSEC
Nov 6, 2024Nov 8, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale106,319$4.8M53.1%UnusualSEC
Nov 6, 2024Nov 6, 2024Avidity Biosciences, Inc.OfficerForm 144 notice106,319$4.8MNoticeSEC
Sep 23, 2024Sep 23, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale11,510$506k10.7%RoutineSEC
Jun 18, 2024Jun 20, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale11,228$439k16.3%RoutineSEC
Jun 12, 2024Jun 14, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale104,245$3.7M70.3%RoutineSEC
Jun 12, 2024Jun 12, 2024Avidity Biosciences, Inc.OfficerForm 144 notice104,245$3MNoticeSEC
May 14, 2024May 16, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale75,000$2.1M63.0%RoutineSEC
May 14, 2024May 14, 2024Avidity Biosciences, Inc.OfficerForm 144 notice75,000$2MNoticeSEC
Mar 13, 2024Mar 15, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale40,000$981k47.6%RoutineSEC
Mar 13, 2024Mar 13, 2024Avidity Biosciences, Inc.DirectorForm 144 notice40,000$908kNoticeSEC
Jan 22, 2024Jan 23, 2024Avidity Biosciences, Inc.Chief Financial OfficerForm 4 sale1,616$16k8.7%RoutineSEC
Aug 2, 2010Aug 3, 2010BIIBSVP, Chief Accounting OfficerForm 4 sale9,542$542k45.1%UnusualSEC
Mar 19, 2010Mar 23, 2010BIIBSVP, Chief Accounting OfficerForm 4 sale4,085$245k16.7%Plan not statedSEC
Jan 19, 2010Jan 19, 2010BIIBSVP, Chief Accounting OfficerForm 4 sale1,389$76k5.6%Plan not statedSEC
Oct 6, 2008Oct 6, 2008BIIBSVP, Chief Accounting OfficerForm 4 sale2,047$102k8.5%Plan not statedSEC
Jul 31, 2008Aug 1, 2008BIIBSVP, Chief Accounting OfficerForm 4 sale1,875$136k7.0%Plan not statedSEC
Jul 22, 2008Jul 24, 2008BIIBSVP, Chief Accounting OfficerForm 4 sale682$48k2.7%Plan not statedSEC
Apr 8, 2008Apr 10, 2008BIIBSVP, Chief Accounting OfficerForm 4 sale2,214$143k8.0%Plan not statedSEC